Risk factors associated with the development of pulmonary thromboembolism in adult patients diagnosed with COVID-19
DOI:
https://doi.org/10.56294/saludcyt2022212Keywords:
Post COVID-19 Disease, Pulmonary Embolism, Risk FactorsAbstract
Introduction: COVID-19 infection encompasses several clinical manifestations ranging from cough, fever, myalgia, dyspnea, fatigue and rhinorrhea to an asymptomatic infection in some of the cases, to this is added and gains importance as a complication of COVID-19 coagulation diseases among which we find pulmonary thromboembolism (PTE), in fact it has been possible to identify patients who have come to die from this cause associated with SARS-CoV-2 infection.
Objective: to describe the risk factors associated with the development of pulmonary thromboembolism in adult patients diagnosed with COVID-19.
Methods: narrative literature review including meta-analyses, systematic reviews, review articles and research articles published in PubMed and Web of Science between 2020-2022.
Conclusions: it was determined that there are risk factors that favor the development of PTE associated with COVID-19, of which we mention some such as age, admission to intensive care units (ICU) and even the patient's sex, it should be emphasized that each of these is related to a greater or lesser extent so they should be considered and associated taking into account that distinction
References
1. Díaz-Castrillón FJ, Toro-Montoya AI. SARS-CoV-2/COVID-19: el virus, la enfermedad y la pandemia. Med Lab. 2020;24(3):183–205. https://doi.org/10.36384/01232576.268.
2. Ciotti M, Ciccozzi M, Terrinoni A, Jiang WC, Wang CB, Bernardini S. The COVID-19 pandemic. Crit Rev Clin Lab Sci. 2020;57(6):365–88. https://doi.org/10.1080/10408363.2020.1783198.
3. Martínez Chamorro E, Revilla Ostolaza TY, Pérez Núñez M, Borruel Nacenta S, Cruz-Conde Rodríguez-Guerra C, Ibáñez Sanz L. Tromboembolismo pulmonar en pacientes con COVID-19: estudio de prevalencia en un hospital terciario. Radiologia. 2021;63(1):13–21. https://doi.org/10.1016/j.rx.2020.09.010.
4. Gil R, Bitar P, Deza C, Dreyse J, Florenzano M, Ibarra C, et al. Cuadro clínico del COVID-19. Rev Médica Clínica Las Condes. 2021;32(1):20–9. https://doi.org/10.1016/j.rmclc.2020.11.004.
5. Vélez-Páez JL, López-Rondón E, Montalvo-Villagómez M. SARS-Cov-2 y tromboembolia pulmonar en pacientes críticamente enfermos, experiencia de una unidad de cuidados críticos. Bionatura. 2021;3(3):1894–5. http://dx.doi.org/10.21931/RB/2021.06.03.2.
6. López Fontalvo J, Ballesteros Palencia SK, Coronado Pulido SY, Arias Botero JH. Incidencia de eventos tromboembólicos venosos en pacientes hospitalizados con COVID-19. Acta Colomb Cuid Intensivo. 2022; 22(1):11-8. http://doi.org/10.1016/j.acci.2022.02.004.
7. Baselga MT, Fernández ML, Marín A, Fernández-Capitán C, Lorenzo A, Martínez-Alés G, et al. Trombosis y COVID-19: revisión de alcance. Acta Colomb Cuid Intensivo. 2022;22(1):11–23. http://doi.org/10.1016/j.acci.2020.09.002.
8. Mestre-Gomez B, Lorente-Ramos RM, Rogado J, Franco-Moreno A, Obispo B, Salazar-Chiriboga D, et al. Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis. J Thromb THROMBOLYSIS. 2021;51(1):40–6. https://doi.org/10.1007/s11239-020-02190-9.
9. Gonzalez-Fajardo JA, Ansuategui M, Romero C, Comanges A, Gómez-Arbeláez D, Ibarra G, et al. Mortalidad de los pacientes covid-19 con complicaciones trombóticas. Med Clínica. 2021;156(3):112–7. http://doi.org/10.1016/j.medcli.2020.10.004.
10. Eirin Rey EJ, Lozano Sanchez X, Cárdenas Caballero O, Figueroa Guevara D, González Carrillo O, Barroso Mesa LM. Nivel de conocimientos sobre COVID-19 en médicos del Policlínico Docente Norte del municipio Placetas. Edumecentro. 2021;13(4):229–42.
11. López-Reyes R, Oscullo G, Jiménez D, Cano I, García-Ortega A. Riesgo trombótico y COVID-19: revisión de la evidencia actual para una mejor aproximación diagnóstica y terapéutica. Arch Bronconeumol. 2021;57:55–64. http://doi.org/10.1016/j.arbres.2020.07.033.
12. Poor HD. Pulmonary Thrombosis and Thromboembolism in COVID-19. Chest. 2021;160(4):1471–80. http://doi.org/10.1016/j.chest.2021.06.016.
13. Bretón I, de Hollanda A, Vilarrasa N, Rubio Herrera MA, Lecube A, Salvador J, et al. Obesidad y COVID-19. Un posicionamiento necesario. Endocrinol Diabetes Nutr. 2021;68(8):573–6. http://doi.org/10.1016/j.endinu.2021.02.001.
14. Rocha MEG, Chagas VM, Carvalho LG, Junior VRS, Aroucha AQMS, Correia MCB, et al. D-DÍMERO elevado em pacientes com COVID-19: relato de uma seguimento clínico e laboratorial em 6 casos confirmados. Hematol Transfus Cell Ther. 2020;42:528–9. http://doi.org/10.1016/j.htct.2020.10.892.
15. García Vallejo O, Frías Vargas M, Gil Gil I, Vázquez Gómez N, Piera Carbonell A, Peiró Morant J. Conocimiento de la tromboprofilaxis-COVID-19 en los profesionales sanitarios en España. Med Fam SEMERGEN. 2021;47(6):361–8. http://doi.org/10.1016/j.semerg.2021.01.002.
16. Scudiero F, Silverio A, Di Maio M, Russo V, Citro R, Personeni D, et al. Pulmonary embolism in COVID-19 patients: prevalence, predictors and clinical outcome. Thromb Res. 2021;198:34–9. https://doi.org/10.1016/j.thromres.2020.11.017.
17. Roncon L, Zuin M, Barco S, Valerio L, Zuliani G, Zonzin P, et al. Incidence of acute pulmonary embolism in COVID-19 patients: Systematic review and meta-analysis. Eur J Intern Med. 2020;82:29–37. https://doi.org/10.1016/j.ejim.2020.09.006.
18. Bobadilla-Rosado LO, Mier y Teran-Ellis S, Lopez-Pena G, Anaya-Ayala JE, Hinojosa CA. Clinical Outcomes of Pulmonary Embolism in Mexican Patients With COVID-19. Clin Appl Thromb. 2021;27:10760296211008988. https://doi.org/10.1177/10760296211008988.
19. Miró Ò, Jiménez S, Mebazaa A, Freund Y, Burillo-Putze G, Martín A, et al. Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome. Eur Heart J. 2021;42(33):3127–42. https://doi.org/10.1093/eurheartj/ehab314.
20. García-Ortega A, Oscullo G, Calvillo P, López-Reyes R, Méndez R, Gómez-Olivas JD, et al. Incidence, risk factors, and thrombotic load of pulmonary embolism in patients hospitalized for COVID-19 infection. J Infect. 2021;82(2):261–9. https://doi.org/10.1016/j.jinf.2021.01.003.
21. Riyahi S, Dev H, Behzadi A, Kim J, Attari H, Raza S I, et al. Pulmonary Embolism in Hospitalized Patients with COVID-19: A Multicenter Study. RADIOLOGY. 2021;301(3):E426–33. https://doi.org/10.1148/radiol.2021210777.
22. Cui LY, Cheng WW, Mou ZW, Xiao D, Li YY, Li YJ, et al. Risk factors for pulmonary embolism in patients with COVID-19: a systemic review and meta-analysis. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2021;111:154–63. https://doi.org/10.1016/j.ijid.2021.08.017.
23. Kollias A, Kyriakoulis KG, Lagou S, Kontopantelis E, Stergiou GS, Syrigos K. Venous thromboembolism in COVID-19: A systematic review and meta-analysis. Vasc Med Lond Engl. 2021;26(4):415–25. https://doi.org/10.1177/1358863X21995566.
24. Bukhari ZM, Alqarni MS, Abukhodair AW, Alzahrani AS, Alzahrani A, Alsrhani H, et al. COVID-9-Related Pulmonary Embolism: Incidence, Characteristics, and Risk Factors. CUREUS J Med Sci. 2021;13(11). http://doi.org/10.7759/cureus.19738.
25. Kwee RM, Adams HJA, Kwee TC. Pulmonary embolism in patients with COVID-19 and value of D-dimer assessment: a meta-analysis. Eur Radiol. 2021;31(11):8168–86. https://doi.org/10.1007/s00330-021-08003-8.
26. Longchamp G, Manzocchi-Besson S, Longchamp A, Righini M, Robert-Ebadi H, Blondon M. Proximal deep vein thrombosis and pulmonary embolism in COVID-19 patients: a systematic review and meta-analysis. Thromb J. 2021;19(1):15. https://doi.org/10.1186/s12959-021-00266-x.
27. Liao SC, Shao SC, Chen YT, Chen YC, Hung MJ. Incidence and mortality of pulmonary embolism in COVID-19: a systematic review and meta-analysis. Crit Care Lond Engl. 2020;24(1):464. https://doi.org/10.1186/s13054-020-03175-z.
Published
Issue
Section
License
Copyright (c) 2022 John Stalyn Guapisaca Gaona, Esthefany Belén Guartambel Cajamarca, Danilo Gustavo Muñoz Palomeque, Mónica Fernanda Angamarca Coello (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
